{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:26:54Z","timestamp":1789608414649,"version":"build-2803163510"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,27]]},"DOI":"10.1097\/tp.0b013e31823104ec","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T13:49:45Z","timestamp":1317736185000},"page":"837-844","source":"Crossref","is-referenced-by-count":67,"title":["Human Herpes Virus 8 in Solid Organ Transplantation"],"prefix":"10.1097","volume":"92","author":[{"given":"Ella J.","family":"Ariza-Heredia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymund R.","family":"Razonable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1743-422X-2-78","article-title":"Human herpesvirus 8\u2014A novel human pathogen.","volume":"2","author":"Edelman","year":"2005","journal-title":"Virol J"},{"key":"R2-1-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/QCO.0b013e3280143919","article-title":"Transmission of human herpesvirus 8: An update.","volume":"20","author":"Pica","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"R3-1-20210129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1399-302X.2008.00481.x","article-title":"Extensive oral shedding of human herpesvirus 8 in a renal allograft recipient.","volume":"24","author":"Al-Otaibi","year":"2009","journal-title":"Oral Microbiol Immunol"},{"key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa055009","article-title":"Transmission of human herpesvirus 8 by blood transfusion.","volume":"355","author":"Hladik","year":"2006","journal-title":"N Engl J Med"},{"key":"R5-1-20210129","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM199811053391903","article-title":"Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients.","volume":"339","author":"Regamey","year":"1998","journal-title":"N Engl J Med"},{"key":"R6-1-20210129","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200011093431905","article-title":"Bone marrow failure associated with human herpesvirus 8 infection after transplantation.","volume":"343","author":"Luppi","year":"2000","journal-title":"N Engl J Med"},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"13045","DOI":"10.1128\/JVI.01455-10","article-title":"Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.","volume":"84","author":"Coleman","year":"2010","journal-title":"J Virol"},{"key":"R8-1-20210129","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1172\/JCI40567","article-title":"KSHV and the pathogenesis of Kaposi sarcoma: Listening to human biology and medicine.","volume":"120","author":"Ganem","year":"2010","journal-title":"J Clin Invest"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2009.07.004","article-title":"Kaposi sarcoma-associated herpesvirus (KSHV): Molecular biology and oncogenesis.","volume":"289","author":"Wen","year":"2010","journal-title":"Cancer Lett"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1079\/PHN2003504","article-title":"Out of the box.","volume":"6","author":"Cannon","year":"2003","journal-title":"Public Health Nutr"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1098\/rstb.2000.0777","article-title":"Molecular virology of Kaposi's sarcoma-associated herpesvirus.","volume":"356","author":"Moore","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(96)03240-0","article-title":"Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.","volume":"348","author":"Lennette","year":"1996","journal-title":"Lancet"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1537-2995.2009.02559.x","article-title":"Human herpesvirus 8 genomes and seroprevalence in United States blood donors.","volume":"50","author":"Qu","year":"2010","journal-title":"Transfusion"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/340237","article-title":"Reactivation of and primary infection with human herpesvirus 8 among solid-organ transplant recipients.","volume":"185","author":"Jenkins","year":"2002","journal-title":"J Infect Dis"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.trim.2006.09.008","article-title":"Human herpesvirus-8 infection and Kaposi's sarcoma after liver and kidney transplantation in different geographical areas of Spain.","volume":"17","author":"Garc\u00eda-Astudillo","year":"2006","journal-title":"Transpl Immunol"},{"key":"R16-1-20210129","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/ndt\/gfm056","article-title":"Human herpes virus 8 infection in kidney transplant patients from an area of northwestern Italy (Piemonte region).","volume":"22","author":"Bergallo","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R17-1-20210129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm0896-925","article-title":"KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.","volume":"2","author":"Gao","year":"1996","journal-title":"Nat Med"},{"key":"R18-1-20210129","first-page":"412","article-title":"Kaposi's sarcoma in Sudanese renal transplant recipients: A report from a single center.","volume":"16","author":"Sabeel","year":"2003","journal-title":"J Nephrol"},{"key":"R19-1-20210129","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11255-008-9483-z","article-title":"Kaposi's sarcoma following living donor kidney transplantation: Review of 7,939 recipients.","volume":"41","author":"Einollahi","year":"2009","journal-title":"Int Urol Nephrol"},{"key":"R20-1-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijid.2005.02.004","article-title":"Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: A critical review of an old disease.","volume":"9","author":"Mohanna","year":"2005","journal-title":"Int J Infect Dis"},{"key":"R21-1-20210129","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/ijc.22233","article-title":"Kaposi's sarcoma risk among transplant recipients in the United States (1993\u20132003).","volume":"119","author":"Mbulaiteye","year":"2006","journal-title":"Int J Cancer"},{"key":"R22-1-20210129","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/blood.V96.9.3279.h8003279_3279_3281","article-title":"Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients.","volume":"96","author":"Luppi","year":"2000","journal-title":"Blood"},{"key":"R23-1-20210129","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.transproceed.2004.06.054","article-title":"Posttransplant Kaposi's sarcoma: Report from a single center.","volume":"36","author":"Huang","year":"2004","journal-title":"Transplant Proc"},{"key":"R24-1-20210129","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1025335718142","article-title":"Role of oral blockade of platelet glycoprotein IIb\/IIIa on neutrophil activation in patients with acute coronary syndromes.","volume":"17","author":"Serrano","year":"2003","journal-title":"Cardiovasc Drugs Ther"},{"key":"R25-1-20210129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.trre.2008.05.004","article-title":"Kaposi sarcoma in transplantation.","volume":"22","author":"Lebb \u00e9","year":"2008","journal-title":"Transplant Rev"},{"key":"R26-1-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/qjmed\/hci028","article-title":"Kaposi's sarcoma in kidney transplant recipients: A 23-year experience.","volume":"98","author":"Moosa","year":"2005","journal-title":"QJM"},{"key":"R27-1-20210129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000184900","article-title":"Posttransplant Kaposi sarcoma: Staging as a guide to therapy and prognosis.","volume":"48","author":"Al-Khader","year":"1988","journal-title":"Nephron"},{"issue":"2","key":"R28-1-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0037-1963(03)70006-7","article-title":"Pathogenesis and manifestations of human herpesvirus-8-associated disorders.","volume":"40","author":"Aoki","year":"2003","journal-title":"Semin Hematol"},{"issue":"1","key":"R29-1-20210129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/dc.2001","article-title":"Primary pleural effusion posttransplant lymphoproliferative disorder: distinction from secondary involvement and effusion lymphoma.","volume":"25","author":"Ohori","year":"2001","journal-title":"Diagn Cytopathol"},{"key":"R30-1-20210129","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJM199808133390705","article-title":"Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient.","volume":"339","author":"Jones","year":"1998","journal-title":"N Engl J Med"},{"key":"R31-1-20210129","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/modpathol.2010.67","article-title":"Notch1 in primary effusion lymphoma: A clinicopathological study.","volume":"23","author":"Wang","year":"2010","journal-title":"Mod Pathol"},{"key":"R32-1-20210129","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.leu.2401390","article-title":"Primary effusion lymphoma after heart transplantation: A new entity associated with human herpesvirus-8.","volume":"13","author":"Dotti","year":"1999","journal-title":"Leukemia"},{"key":"R33-1-20210129","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1600-6143.2008.02156.x","article-title":"Pleural primary effusion lymphoma in a renal transplant recipient.","volume":"8","author":"Melo","year":"2008","journal-title":"Am J Transplant"},{"key":"R34-1-20210129","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1600-6143.2007.02110.x","article-title":"Human herpesvirus-8 (HHV-8)-associated primary effusion lymphoma in two renal transplant recipients receiving rapamycin.","volume":"8","author":"Boulanger","year":"2008","journal-title":"Am J Transplant"},{"key":"R35-1-20210129","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2005-08-3213","article-title":"Severe human herpesvirus-8 primary infection in a renal transplant patient successfully treated with anti-CD20 monoclonal antibody.","volume":"107","author":"Thaunat","year":"2006","journal-title":"Blood"},{"key":"R36-1-20210129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-6143.2010.03366.x","article-title":"Post-liver transplantation multicentric Castleman disease treated with valganciclovir and weaning of immunosuppression.","volume":"11","author":"Lim","year":"2011","journal-title":"Am J Transplant"},{"key":"R37-1-20210129","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1365-2559.2007.02702.x","article-title":"Concomitant and fatal HHV-8+ multicentric Castleman's disease and Kaposi's sarcoma in the same lymph node of an HIV-liver transplant patient.","volume":"50","author":"Gaitonde","year":"2007","journal-title":"Histopathology"},{"key":"R38-1-20210129","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.transproceed.2007.03.059","article-title":"Post renal transplant Castleman's disease resolved after graft nephrectomy: A case report.","volume":"39","author":"Al Otaibi","year":"2007","journal-title":"Transplant Proc"},{"key":"R39-1-20210129","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2141.2001.02740.x","article-title":"Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma.","volume":"113","author":"Kapelushnik","year":"2001","journal-title":"Br J Haematol"},{"key":"R40-1-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.annder.2010.01.011","article-title":"[Primary effusion lymphoma in two kidney transplant recipients].","volume":"137","author":"R\u00e9gnier-Rosencher","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"R41-1-20210129","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200011093431905","article-title":"Bone marrow failure associated with human herpesvirus 8 infection after transplantation.","volume":"343","author":"Luppi","year":"2000","journal-title":"N Engl J Med"},{"key":"R42-1-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00007890-200207150-00023","article-title":"Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet.","volume":"74","author":"Luppi","year":"2002","journal-title":"Transplantation"},{"issue":"1","key":"R43-1-20210129","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1054\/bjoc.2000.1527","article-title":"A prospective seroepidemiological study of human herpesvirus-8 infection and the risk of multiple myeloma.","volume":"84","author":"Tedeschi","year":"2001","journal-title":"Cr J Cancer"},{"issue":"4","key":"R44-1-20210129","first-page":"461","article-title":"The roles of human viruses in the pathogenesis of lymphoma.","volume":"25","author":"Lyons","year":"1998","journal-title":"Semin Oncol"},{"issue":"suppl 4","key":"R45-1-20210129","first-page":"S100","article-title":"HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients.","volume":"9","author":"Razonable","year":"2009","journal-title":"Am J Transplant"},{"key":"R46-1-20210129","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/CDLI.8.5.913-921.2001","article-title":"Comparison of serologic assays for detection of antibodies against human herpesvirus 8.","volume":"8","author":"Corchero","year":"2001","journal-title":"Clinical Diagn Lab Immunol"},{"key":"R47-1-20210129","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/00002030-200009290-00006","article-title":"Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage.","volume":"14","author":"Campbell","year":"2000","journal-title":"AIDS"},{"issue":"3","key":"R48-1-20210129","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcv.2008.07.005","article-title":"Human herpesvirus 8 DNA quantification in matched plasma and PBMC samples of patients with HHV-8 related lymphoproliferative diseases.","volume":"43","author":"Tedeschi","year":"2008","journal-title":"J Clin Virol"},{"key":"R49-1-20210129","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1128\/JCM.39.12.4269-4273.2001","article-title":"Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.","volume":"39","author":"Tedeschi","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R50-1-20210129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1086\/341088","article-title":"Prognostic value of quantitative Kaposi sarcoma-associated herpesvirus load in posttransplantation Kaposi sarcoma.","volume":"186","author":"Pellet","year":"2002","journal-title":"J Infect Dis"},{"key":"R51-1-20210129","first-page":"411","article-title":"Transplant infections.","author":"Singh","year":"2010"},{"key":"R52-1-20210129","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1200\/JCO.1997.15.6.2371","article-title":"Treatment of Kaposi's sarcoma after solid organ transplantation.","volume":"15","author":"Shepherd","year":"1997","journal-title":"J Clin Oncol"},{"key":"R53-1-20210129","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/TP.0b013e318184112c","article-title":"Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma.","volume":"86","author":"Barozzi","year":"2008","journal-title":"Transplantation"},{"key":"R54-1-20210129","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1432-2277.2008.00697.x","article-title":"Kaposi's sarcoma and mTOR: A crossroad between viral infection neoangiogenesis and immunosuppression.","volume":"21","author":"Stallone","year":"2008","journal-title":"Transpl Int"},{"key":"R55-1-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/TP.0b013e318193886e","article-title":"The role of mTOR inhibitors in the management of posttransplant malignancy.","volume":"87","author":"Monaco","year":"2009","journal-title":"Transplantation"},{"key":"R56-1-20210129","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1034\/j.1600-6143.2002.20911.x","article-title":"Successful treatment of post-renal transplant Kaposi's sarcoma with paclitaxel.","volume":"2","author":"Patel","year":"2002","journal-title":"Am J Transplant"},{"key":"R57-1-20210129","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1365-2133.2008.08517.x","article-title":"Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: Experience in 17 cases.","volume":"158","author":"Brambilla","year":"2008","journal-title":"Br J Dermatol"},{"key":"R58-1-20210129","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"key":"R59-1-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/588820","article-title":"Valganciclovir for suppression of human herpesvirus-8 replication: A randomized, double-blind, placebo-controlled, crossover trial.","volume":"198","author":"Casper","year":"2008","journal-title":"J Infect Dis"},{"key":"R60-1-20210129","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1111\/j.1600-6143.2009.02816.x","article-title":"The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survival.","volume":"9","author":"Franc\u00e8s","year":"2009","journal-title":"Am J Transplant"},{"key":"R61-1-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1034\/j.1399-3046.2002.02006.x","article-title":"Human herpesvirus type 8 infections among solid organ transplant recipients.","volume":"6","author":"Allen","year":"2002","journal-title":"Pediatr Transplant"},{"key":"R62-1-20210129","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archderm.134.6.700","article-title":"Prevalence of human herpesvirus 8 infection measured by antibodies to a latent nuclear antigen in patients with various dermatologic diseases.","volume":"134","author":"Dupin","year":"1998","journal-title":"Arch Dermatol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-201110270-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:22:44Z","timestamp":1786047764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201110270-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,27]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e31823104ec","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,27]]}}}